Latest Insider Transactions at Ambac Financial Group Inc (AMBC)
This section provides a real-time view of insider transactions for Ambac Financial Group Inc (AMBC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AMBAC FINANCIAL GROUP INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AMBAC FINANCIAL GROUP INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2024
|
Kristi Ann Matus Director |
BUY
Open market or private purchase
|
Direct |
6,300
+41.18%
|
$69,300
$11.16 P/Share
|
|
Sep 26
2024
|
Kristi Ann Matus Director |
BUY
Open market or private purchase
|
Direct |
2,700
+50.0%
|
$29,700
$11.27 P/Share
|
|
Aug 08
2024
|
R Sharon Smith Exec VP & Chief Strategy Offr |
BUY
Open market or private purchase
|
Direct |
1,100
+1.45%
|
$11,000
$10.64 P/Share
|
|
Aug 07
2024
|
Jeffrey Scott Stein Director |
BUY
Open market or private purchase
|
Direct |
25,000
+41.67%
|
$250,000
$10.82 P/Share
|
|
Aug 07
2024
|
David Trick Exec VP, CFO & Treasurer |
BUY
Open market or private purchase
|
Direct |
3,700
+0.59%
|
$37,000
$10.75 P/Share
|
|
Aug 07
2024
|
Claude Le Blanc Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
25,000
+0.94%
|
$250,000
$10.76 P/Share
|
|
Aug 07
2024
|
Michael D Price Director |
BUY
Open market or private purchase
|
Direct |
89,312
+34.64%
|
$982,432
$11.01 P/Share
|
|
Aug 07
2024
|
Stephen Michael Ksenak Sr. MD & General Counsel |
BUY
Open market or private purchase
|
Direct |
5,000
+4.11%
|
$55,000
$11.0 P/Share
|
|
Mar 08
2024
|
Claude Le Blanc Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,193
-0.24%
|
$17,895
$15.38 P/Share
|
|
Mar 08
2024
|
Claude Le Blanc Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,193
+0.24%
|
-
|
|
Mar 08
2024
|
David Trick Exec VP, CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
270
-0.18%
|
$4,050
$15.38 P/Share
|
|
Mar 08
2024
|
David Trick Exec VP, CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
270
+0.18%
|
-
|
|
Mar 08
2024
|
R Sharon Smith Exec VP & Chief Strategy Offr |
SELL
Payment of exercise price or tax liability
|
Direct |
233
-0.32%
|
$3,495
$15.38 P/Share
|
|
Mar 08
2024
|
R Sharon Smith Exec VP & Chief Strategy Offr |
BUY
Exercise of conversion of derivative security
|
Direct |
233
+0.31%
|
-
|
|
Mar 08
2024
|
Robert Bryan Eisman Sr. MD & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
87
-0.13%
|
$1,305
$15.38 P/Share
|
|
Mar 08
2024
|
Robert Bryan Eisman Sr. MD & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
87
+0.13%
|
-
|
|
Mar 08
2024
|
David Barranco Senior Managing Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,523
-2.21%
|
$37,845
$15.38 P/Share
|
|
Mar 08
2024
|
David Barranco Senior Managing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,001
+5.77%
|
-
|
|
Mar 08
2024
|
Stephen Michael Ksenak Sr. MD & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
218
-0.19%
|
$3,270
$15.38 P/Share
|
|
Mar 08
2024
|
Stephen Michael Ksenak Sr. MD & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
218
+0.19%
|
-
|
|
Mar 03
2024
|
Claude Le Blanc Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
888
-0.18%
|
$14,208
$16.19 P/Share
|
|
Mar 03
2024
|
Claude Le Blanc Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
888
+0.18%
|
-
|
|
Mar 03
2024
|
R Sharon Smith Exec VP & Chief Strategy Offr |
SELL
Payment of exercise price or tax liability
|
Direct |
179
-0.24%
|
$2,864
$16.19 P/Share
|
|
Mar 03
2024
|
R Sharon Smith Exec VP & Chief Strategy Offr |
BUY
Exercise of conversion of derivative security
|
Direct |
179
+0.24%
|
-
|
|
Mar 03
2024
|
Stephen Michael Ksenak Sr. MD & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
163
-0.15%
|
$2,608
$16.19 P/Share
|
|
Mar 03
2024
|
Stephen Michael Ksenak Sr. MD & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
163
+0.15%
|
-
|
|
Mar 03
2024
|
David Trick Exec VP, CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
201
-0.13%
|
$3,216
$16.19 P/Share
|
|
Mar 03
2024
|
David Trick Exec VP, CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
201
+0.13%
|
-
|
|
Mar 03
2024
|
David Barranco Senior Managing Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,880
-1.72%
|
$30,080
$16.19 P/Share
|
|
Mar 03
2024
|
David Barranco Senior Managing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,215
+4.56%
|
-
|
|
Mar 03
2024
|
Daniel Mc Ginnis Sr. MD & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
92
-1.09%
|
$1,472
$16.19 P/Share
|
|
Mar 03
2024
|
Daniel Mc Ginnis Sr. MD & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
92
+1.08%
|
-
|
|
Mar 03
2024
|
Robert Bryan Eisman Sr. MD & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
65
-0.1%
|
$1,040
$16.19 P/Share
|
|
Mar 03
2024
|
Robert Bryan Eisman Sr. MD & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
65
+0.1%
|
-
|
|
Feb 28
2024
|
David Trick Exec VP, CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
220
-0.14%
|
$3,520
$16.94 P/Share
|
|
Feb 28
2024
|
David Trick Exec VP, CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
220
+0.14%
|
-
|
|
Feb 28
2024
|
Claude Le Blanc Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
975
-0.19%
|
$15,600
$16.94 P/Share
|
|
Feb 28
2024
|
Claude Le Blanc Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
975
+0.19%
|
-
|
|
Feb 28
2024
|
Daniel Mc Ginnis Sr. MD & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,928
-15.62%
|
$46,848
$16.94 P/Share
|
|
Feb 28
2024
|
Daniel Mc Ginnis Sr. MD & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,072
+22.57%
|
-
|
|
Feb 28
2024
|
Robert Bryan Eisman Sr. MD & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
71
-0.1%
|
$1,136
$16.94 P/Share
|
|
Feb 28
2024
|
Robert Bryan Eisman Sr. MD & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
71
+0.1%
|
-
|
|
Feb 28
2024
|
David Barranco Senior Managing Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,063
-1.95%
|
$33,008
$16.94 P/Share
|
|
Feb 28
2024
|
David Barranco Senior Managing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,723
+5.12%
|
-
|
|
Feb 28
2024
|
Stephen Michael Ksenak Sr. MD & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
178
-0.16%
|
$2,848
$16.94 P/Share
|
|
Feb 28
2024
|
Stephen Michael Ksenak Sr. MD & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
178
+0.16%
|
-
|
|
Feb 28
2024
|
R Sharon Smith Exec VP & Chief Strategy Offr |
SELL
Payment of exercise price or tax liability
|
Direct |
196
-0.27%
|
$3,136
$16.94 P/Share
|
|
Feb 28
2024
|
R Sharon Smith Exec VP & Chief Strategy Offr |
BUY
Exercise of conversion of derivative security
|
Direct |
196
+0.26%
|
-
|
|
Feb 21
2024
|
David Barranco Senior Managing Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,143
-2.09%
|
$34,288
$16.25 P/Share
|
|
Feb 21
2024
|
David Barranco Senior Managing Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,143
+2.05%
|
-
|